预测结直肠内镜黏膜下剥离术后迟发性出血的风险评分模型
这项在5个中心开展的回顾性研究,用来自1个中心的1189例患者建立预测结直肠内镜黏膜下剥离术后迟发性出血的风险评分模型,并在另外4个中心的415例患者中验证。 derivation队列中迟发性出血发生率为2.9%,危险因素包括直肠乙状结肠肿瘤位置、肿瘤≥30 mm及使用除阿司匹林外的抗血小板药物,评分越高出血发生率越高。
要点
- 结直肠内镜黏膜下剥离术后迟发性出血的独立危险因素为直肠乙状结肠位置、肿瘤≥30 mm及使用除阿司匹林外的抗血小板药物。
- 基于上述3个因素构建的风险评分模型在验证队列中显示,评分越高迟发性出血发生率越高。
- 该模型可定量预测结直肠内镜黏膜下剥离术后迟发性出血风险。
核心结论
- 包含肿瘤位置、肿瘤大小和使用抗血小板药物3个因素的风险评分模型可定量预测结直肠内镜黏膜下剥离术后迟发性出血风险。
研究设计与样本
- 回顾性研究,在5个中心开展;derivation队列为来自1个中心的1189例患者,验证队列为来自另外4个中心的415例患者。
主要发现
- derivation队列中34例(2.9%)发生迟发性出血。
- 多因素分析显示迟发性出血的危险因素为直肠乙状结肠肿瘤位置(OR 6.49;95%CI 1.96-21.42;P = .002)。
- 多因素分析显示迟发性出血的危险因素为肿瘤≥30 mm(OR 2.10;95%CI 1.01-4.40;P = .048)。
- 多因素分析显示迟发性出血的危险因素为使用除阿司匹林外的抗血小板药物(OR 4.04;95%CI 1.44-11.30;P = .008)。
- 验证队列中,随着该评分系统得分升高,迟发性出血发生率升高。
关键数值与推荐
- 风险评分模型纳入直肠乙状结肠肿瘤位置、肿瘤≥30 mm及使用除阿司匹林外的抗血小板药物3个因素。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Delayed bleeding is an important adverse event after colorectal endoscopic submucosal dissection (ESD). We aimed to investigate the incidence and risk factors of delayed bleeding after colorectal ESD and to develop a risk-scoring model for predicting delayed bleeding. METHODS: This retrospective study was performed at 5 centers. The derivation and validation cohorts comprised 1189 patients from 1 center and 415 patients from the other 4 centers. We investigated the incidence and risk factors of delayed bleeding. Then, we developed a risk-scoring model for predicting delayed bleeding by using the data of the derivation cohort. We validated the scoring system in the validation cohort. RESULTS: Delayed bleeding occurred in 34 patients (2.9%) in the derivation cohort. In multivariate analysis, the risk factors of delayed bleeding were tumor location in the rectosigmoid colon (odds ratio [OR], 6.49; 95% confidence interval [CI], 1.96-21.42; P = .002), large tumor (≥30 mm) (OR, 2.10; 95% CI, 1.01-4.40; P = .048), and use of antiplatelet agents except for aspirin alone (OR, 4.04; 95% CI, 1.44-11.30; P = .008). These 3 factors were incorporated into a risk-scoring model for prediction of delayed bleeding. As the score based on this system increased, the incidence of delayed bleeding increased in the validation cohort. CONCLUSION: The risk-scoring model incorporating tumor location, tumor size, and use of antiplatelet agents can quantitatively predict the risk of delayed bleeding after colorectal ESD.
引用
- Seo M, Song EM, Cho JW, et al. A risk-scoring model for the prediction of delayed bleeding after colorectal endoscopic submucosal dissection. Gastrointest Endosc. 2018. PMID: 30521794. doi:10.1016/j.gie.2018.11.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。